Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Tunis Med ; 101(5): 486-490, 2023 May 05.
Artículo en Inglés | MEDLINE | ID: mdl-38372515

RESUMEN

INTRODUCTION: Childhood uveitis is a rare condition with various associated diagnostic and therapeutic challenges. AIM: We proposed to describe the distribution, clinical findings, treatment, complications, and visual outcomes of uveitis in children at a tertiary referral center in Sfax, Tunisia. METHODS: A retrospective study of 33 children (54 eyes) with uveitis collected over the period from January 2009 to December 2018 was carried out at the Ophthalmology Department of Habib Bourguiba University Hospital, Sfax, Tunisia. The data from the clinical examination, the etiological assessment, and the used treatments were collected. Standard diagnostic criteria were used for all uveitic syndromes or entities. RESULTS: The mean age of the patients was 11.42 years with a male-to-female ratio of 0.74. Uveitis was bilateral in 63% of the patients. The most common anatomical form was intermediate uveitis (39%). Idiopathic cases accounted for 52%. The major complications were posterior synechiae, optic disc edema, cataract, and cystoid macular edema. Anti-infective treatment was prescribed in 24% of the patients. Oral corticosteroid therapy was used in 67% of the patients. 18% of the patients received immunosuppressive therapy and 6% received a biological agent. The mean final visual acuity was 4.6/10. CONCLUSION: Childhood uveitis is a serious pathology with frequent and vision-threatening complications. The etiologies are variable and the assessment can remain negative. A rigorous diagnostic approach, an oriented etiological assessment in collaboration with the pediatrician, and an appropriate therapy are necessary for management.


Asunto(s)
Catarata , Uveítis , Niño , Humanos , Masculino , Femenino , Estudios Retrospectivos , Túnez/epidemiología , Uveítis/diagnóstico , Uveítis/tratamiento farmacológico , Uveítis/epidemiología , Centros de Atención Terciaria
2.
Tunis Med ; 97(1): 106-112, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31535701

RESUMEN

AIM: To illustrate the various clinical features and management of presumed tuberculous uveitis in an endemic area in Tunisia. METHODS: This is a retrospective study including 14 patients (26 eyes) diagnosed with presumed tuberculous uveitis at the Department of Ophthalmology Habib Bourguiba University Hospital of Sfax-Tunisia. RESULTS: Mean age at onset was 31.7 years. Uveitis was bilateral in 86 % of cases (12 eyes). Panuveitis was the most common manifestation and represented 50% of cases (13 eyes). Ocular findings include mutton-fat keratic precipitates in 35% of cases (9 eyes), posterior synechiae in 31% of cases (8 eyes), vitritis in 81% of cases (21eyes), multifocal choroiditis in 23% of cases (6 eyes), periphlebitis in 27% of cases (7 eyes), and macular edema in 42% of cases (11eyes). Anti-tubercular treatment was prescribed in all patients and was associated with systemic corticosteroids in 71% of cases (10 patients). After a mean follow-up of 16.27 months (range, 6-36), inflammation was controlled with improvement in visual acuity. Recurrence developed in 7 % of cases (1 patient). CONCLUSION: In the present study, posterior synechiae, vitritis, multifocal choroiditis, and retinal vasculitis are the most common manifestations of tuberculous uveitis in tuberculosis endemic area in Tunisia. These manifestations are suggestive of a tubercular cause of uveitis and merit specific treatment.


Asunto(s)
Antituberculosos/uso terapéutico , Tuberculosis Ocular/diagnóstico , Tuberculosis Ocular/tratamiento farmacológico , Uveítis/diagnóstico , Uveítis/tratamiento farmacológico , Adolescente , Adulto , Diagnóstico Diferencial , Técnicas de Diagnóstico Oftalmológico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Prueba de Tuberculina , Tuberculosis Ocular/epidemiología , Túnez/epidemiología , Uveítis/epidemiología , Agudeza Visual/efectos de los fármacos , Adulto Joven
3.
Tunis Med ; 96(6): 335-338, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30430469

RESUMEN

Adherence to medical treatment in primary open angle glaucoma is key to the success of the treatment. Most of the work show that glaucoma patients are poor observant. Poor adherence is multifactorial. The analysis of these factors is crucial. That is why the author wanted to expose, through a literature review, the main determinants of adherence in glaucoma.


Asunto(s)
Glaucoma de Ángulo Abierto/tratamiento farmacológico , Cumplimiento de la Medicación , Humanos , Factores de Riesgo , Resultado del Tratamiento
4.
Int Ophthalmol ; 36(5): 623-8, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26757935

RESUMEN

The purpose of this study is to compare the effect of topical diclofenac and topical dexamethasone on anterior chamber flare and postoperative pain following rhegmatogenous retinal detachment (RRD) surgery. This prospective study included 40 eyes of 40 patients treated for RRD. Twenty-eight patients underwent scleral buckling and 12 patients underwent 20-gauge pars plana vitrectomy (PPV). For each surgical procedure, patients were postoperatively randomly divided into two groups: the first group received topical dexamethasone phosphate 0.1 % four times daily for 28 days; the second group received topical diclofenac sodium 0.1 % three times daily for 28 days. The inflammatory reaction in the anterior chamber was measured with laser flare photometry preoperatively and 1, 7, 14, 28, and 90 days postoperatively. Pain level was evaluated with Scott's visual analog scale at day 1, 7, 14, and 28 postoperatively. For patients treated with scleral buckling, there was no significant difference between the two groups regarding mean aqueous flare at day 1 (p = 0.096), day 7 (p = 0.435), day 14 (p = 0.510), day 28 (p = 0.583), and day 90 (p = 0.423). The group who received diclofenac had significantly lower pain score at days 7, 14, and 28 (p = 0.048, p = 0.017, and p = 0.028, respectively). For patients treated with PPV, there was no significant difference between the two groups regarding mean aqueous flare at day 1 (p = 0.400), day 7 (p = 0.728), day 14 (p = 0.843), day 28 (p = 0.939), and day 90 (p = 0.568). Patients who received diclofenac had significantly lower pain score at days 7, 14, and 28 (p = 0.032, p = 0.030, and p = 0.023, respectively). Topical diclofenac seems to be as potent as topical dexamethasone in managing postoperative inflammatory response induced by surgery for RRD with better analgesic effect. Both of them are consequences of blood-aqueous barrier and blood-retinal barrier breakdown.


Asunto(s)
Dexametasona/uso terapéutico , Diclofenaco/uso terapéutico , Dolor Ocular/tratamiento farmacológico , Dolor Postoperatorio/tratamiento farmacológico , Desprendimiento de Retina/cirugía , Uveítis Anterior/tratamiento farmacológico , Administración Tópica , Adolescente , Adulto , Anciano , Cámara Anterior/efectos de los fármacos , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/uso terapéutico , Niño , Dexametasona/administración & dosificación , Diclofenaco/administración & dosificación , Dolor Ocular/diagnóstico , Femenino , Glucocorticoides/administración & dosificación , Glucocorticoides/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Soluciones Oftálmicas , Dimensión del Dolor , Dolor Postoperatorio/diagnóstico , Fotometría , Estudios Prospectivos , Curvatura de la Esclerótica , Uveítis Anterior/diagnóstico , Vitrectomía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA